90 related articles for article (PubMed ID: 29213040)
21. Brivaracetam and topiramate serum levels during pregnancy and delivery: a case report and a review of literature.
Hahn W; Möller L; Menzler K; Poeplau T; Wagner U; Knake S
Neurol Res Pract; 2024 Mar; 6(1):17. PubMed ID: 38509597
[TBL] [Abstract][Full Text] [Related]
22. Towards realizing the vision of precision medicine: AI based prediction of clinical drug response.
de Jong J; Cutcutache I; Page M; Elmoufti S; Dilley C; Fröhlich H; Armstrong M
Brain; 2021 Jul; 144(6):1738-1750. PubMed ID: 33734308
[TBL] [Abstract][Full Text] [Related]
23. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model.
Sanon NT; Gagné J; Wolf DC; Aboulamer S; Bosoi CM; Simard A; Messiet E; Desgent S; Carmant L
Epilepsy Behav; 2018 Feb; 79():117-125. PubMed ID: 29287214
[TBL] [Abstract][Full Text] [Related]
24. Brivaracetam add-on therapy for drug-resistant epilepsy.
Bresnahan R; Panebianco M; Marson AG
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011501. PubMed ID: 30920649
[TBL] [Abstract][Full Text] [Related]
25. Brivaracetam in the treatment of epilepsy: a review of clinical trial data.
Feyissa AM
Neuropsychiatr Dis Treat; 2019; 15():2587-2600. PubMed ID: 31571877
[TBL] [Abstract][Full Text] [Related]
26. A review of the pharmacology and clinical efficacy of brivaracetam.
Klein P; Diaz A; Gasalla T; Whitesides J
Clin Pharmacol; 2018; 10():1-22. PubMed ID: 29403319
[TBL] [Abstract][Full Text] [Related]
27. Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland.
Väätäinen S; Soini E; Peltola J; Charokopou M; Taiha M; Kälviäinen R
Adv Ther; 2020 Jan; 37(1):477-500. PubMed ID: 31808053
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials.
Ma J; Huang S; You C
Epilepsy Res; 2015 Aug; 114():59-65. PubMed ID: 26088886
[TBL] [Abstract][Full Text] [Related]
29. [Brivaracetam in the treatment of patients with epilepsy].
Karlov VA; Vlasov PN; Zhidkova IA; Kissin MY; Lebedeva AV; Lipatova LV; Mkrtchyan VR; Mukhin KY; Rudakova IG
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9. Vyp. 2):55-62. PubMed ID: 29213040
[TBL] [Abstract][Full Text] [Related]
30. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
Klitgaard H; Matagne A; Nicolas JM; Gillard M; Lamberty Y; De Ryck M; Kaminski RM; Leclercq K; Niespodziany I; Wolff C; Wood M; Hannestad J; Kervyn S; Kenda B
Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study.
Asadi-Pooya AA; Sperling MR; Chung S; Klein P; Diaz A; Elmoufti S; Schiemann J; Whitesides J
Epilepsy Res; 2017 Mar; 131():70-75. PubMed ID: 28279891
[TBL] [Abstract][Full Text] [Related]
32. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
33. Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: Post-hoc analysis of a randomized, placebo-controlled trial.
Klein P; McLachlan R; Foris K; Nondonfaz X; Elmoufti S; Dimova S; Brandt C
Epilepsy Res; 2020 Nov; 167():106369. PubMed ID: 32717713
[TBL] [Abstract][Full Text] [Related]
34. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
